Pliant Therapeutics, Inc. (PLRX) earnings
Quarterly results of Pliant Therapeutics, Inc. as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.
Next earnings date
Pliant Therapeutics, Inc. is expected to report around November 23, 2026. That is an estimate from its filing rhythm (the usual gap between its reports), not a date the company has announced.
Latest quarter: Q2 FY2026
In Q2 FY2026 (ended June 30, 2026) Pliant Therapeutics, Inc. reported revenue of - and a net loss of $22.4M.
Diluted earnings per share were -$0.36.
Quarter by quarter
| Quarter | Revenue | vs year ago | Net income | EPS |
|---|---|---|---|---|
| Q2 FY2026 | - | - | -$22.4M | -$0.36 |
| Q1 FY2026 | - | - | -$20M | -$0.32 |
| Q4 FY2025 | - | - | -$23.6M | - |
| Q3 FY2025 | - | - | -$26.3M | -$0.43 |
| Q2 FY2025 | - | - | -$43.3M | -$0.71 |
| Q1 FY2025 | - | - | -$56.2M | -$0.92 |
| Q4 FY2024 | $0 | - | -$49.7M | - |
| Q3 FY2024 | $0 | - | -$57.8M | -$0.95 |
Results filings
- Quarterly results 8-K
- Quarterly report 10-Q
- Quarterly report 10-Q
- Quarterly results 8-K
- Quarterly results 8-K
- Annual report 10-K
When is Pliant Therapeutics, Inc.'s next earnings date?
Pliant Therapeutics, Inc. is expected to report around November 23, 2026. That is an estimate from its filing rhythm (the usual gap between its reports), not a date the company has announced.
Get an email when PLRX reports
Follow PLRX and we email you its next results the day they are filed, with the numbers explained.